Transcriptional regulation by steroid hormones

Steroids

Volumn 61, Issue 4, 1996, Pages 240-251

  Beato, Miguel ^a   Chávez, Sebastián ^a,b   Truss, Mathias ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

chromatin structure; MMTV promoter; steroid hormone receptor

Indexed keywords

STEROID HORMONE; STEROID RECEPTOR;

CONFERENCE PAPER; DNA BINDING; DNA SEQUENCE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HORMONE BINDING; HORMONE RESPONSIVE ELEMENT; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; TUMOR VIRUS;

EID: 0343985350     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00030-X     Document Type: Conference Paper

References (176)

1. Beato M (1989). Gene regulation by steroid hormones. Cell 56: 335-344.
2. Danielian PS, White R, Lees JA, Parker MG (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033.
3. Schwabe JWR, Chapman L, Finch JT, Rhodes D (1993). The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75:567-578.
4. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-382.
5. Dahlman-Wright K, Baumann H, McEwan IJ, Almlof T, Wright APH, Gustafsson JA, Härd T (1995). Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci USA 92:1699-1703.
6. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP (1993). Human progesterone receptor - A form is a cell-specific and promoter-specific repressor of human progesterone receptor-B function. Mol Endocrinol 7:1244-1255.
7. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM (1985). Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635-641.
8. Bamberger CM, Bamberger AM, DeCastro M, Chrousos GP (1995). Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-2441.
9. Rexin M, Busch W, Segnitz B, Gehring U (1992). Structure of the glucocorticoid receptor in intact cells in the absence of hormone. J Biol Chem 267:9619-9621.
10. Rehberger P, Rexin M, Gehring U (1992). Heterotetrameric structure of the human progesterone receptor. Proc Natl Acad Sci USA 89:8001-8005.
11. Segnitz B, Gehring U (1995). Subunit structure of the nonactivated human estrogen receptor. Proc Natl Acad Sci USA 92:2179-2183.
12. Hutchison KA, Kittmar KD, Pratt WB (1994). All of the factors required for assembly of the glucocorticoid receptor into a functional heterocomplex with heat shock protein 90 are preassociated in a self-sufficient protein folding structure, a "foldosome." J Biol Chem 269:27894-27899.
13. Renoir JM, Mercierbodard C, Hoffmann K, Lebihan S, Ning YM, Sanchez ER, Handschumacher RE, Baulieu EE (1995). Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Proc Natl Acad Sci USA 92:4977-4981.
14. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR (1990). Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348:166-168.
15. Caplan AJ, Langley E, Wilson EM, Vidai J (1995). Hormone-dependent transactivation by the human androgen receptor is regulated by a DNAJ protein. J Biol Chem 270:5251-5257.
16. Kimura Y, Yahara I, Lindquist S (1995). Role of protein chaperone YDJ1 in establishing hsp90-mediated signal transduction pathways. Science 268:1362-1365.
17. Sadovsky Y, Webb P, Lopez G, Baxter JD, Fitzpatrick PM, Gizang-Ginsberg E, Cavailles V, Parker MG, Kushner PJ (1995). Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol 15:1554-1563.
18. Tjian R, Maniatis T (1994). Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5-8.
19. Verrijzer CP, Chen JL, Yokomori K, Tjian R (1995). Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell 81:1115-1125.
20. II30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-117.
21. II 10 subunit of the TFIID complex. J Biol Chem 270:(in press).
22. Hoey T, Weinzierl ROJ, Gill G, Chen JL, Dynlacht BD, Tjian R (1993). Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 72:247-260.
23. Ferreri K, Gill G, Montminy M (1994). The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex. Proc Natl Acad Sci USA 91:1210-1213.
24. Ing NH, Beekman JM, Tsai SY, Tsai MJ, O'Malley BW (1992). Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J Biol Chem 267:17617-17623.
25. Haviv I, Vaizel D, Shaul Y (1995). The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 15: 1079-1085.
26. Chrivia JC, Kwok RPS, Lamb N, Hagiwara M, Montminy MR, Goodman RH (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
27. Kwok RPS, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SGE, Green MR, Goodman RH (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226.
28. Arany Z, Sellers WR, Livingston DM, Eckner R (1994). EIA-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
29. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R (1995). A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81-84.
30. Yu L, Zhang Z, Loewenstein PM, Desai K, Tang Q, Mao D, Symington JS, Green M (1995). Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain. J Virol 69:3007-3016.
31. Halachmi S, Marden E, Martin G, Mackay H, Abbondanza C, Brown M (1994). Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
32. Cavaillès V, Dauvois S, Danielian PS, Parker MG (1994). Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013.
33. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG (1995). Nuclear factor RIP 140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751.
34. Eggert M, Möws CC, Tripier D, Arnold R, Michel J, Nickel J, Schmidt S, Beato M, Renkawitz R (1995). A fraction enriched in a novel glucocorticoid receptor interacting protein stimulates receptor dependent transcription in vitro. J Biol Chem (in press).
35. Baniahmad C, Nawaz Z, Baniahmad A, Gleeson MAG, Tsai MJ, O'Malley BW (1995). Enhancement of human estrogen receptor activity by SPT6: A potential coactivator. Mol Endocrinol 9:34-43.
36. Zeiner M, Gehring U (1995). A novel protein that interacts with members of the nuclear receptor family. Proc Natl Acad Sci USA (in press).
37. LeDouarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P et al. (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033.
38. Guiochon-Mantel A, Savouret JF, Qignon F, Delabre K, Milgrom E, De The H (1995). Effect of PML and PML-RAR on the transcription properties and subcellular distribution of steroid hormone receptors. Mol Endocrinol
39. Inoue S, Orimo A, Hosoi T, Kondo S, Toyoshima H, Kondo T, Ikegami A, Ouchi Y, Orimo H et al. (1993). Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc Natl Acad Sci USA 90:11117-11121.
40. Thummel C (1995). Steroids and Flies. Drosophila metamorphosis provides insights into the molecular mechanism of steroid hormone action. Cell (in press).
41. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD (1995). Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
42. vom Baur E, Zechel C, Heery D, Heine M, Gamier JM, Vivat V, LeDouarin B, Gronemeyer H, Chambon P et al. (1995). Differential ligand-dependent interactions between the AF-2 activation domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15: in press.
43. Swaffield JC, Melcher K, Johnston SA (1995). A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein. Nature 374:88-91.
44. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD (1995). Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254.
45. Onate SA, Tsai SY, Tsai M-J, O'Malley BW (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
46. Hörlein A, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M et al. (1995). Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
47. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995). Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451-454.
48. Chen JD, Evans RM (1995). A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
49. Burris TP, Nawaz Z, Tsai MJ, O'Malley BW (1995). A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc Natl Acad Sci USA 92:9525-9529.
50. Schüle R, Muller M, Otsuka-Murakami H, Renkawitz R (1988). Many transcription factors interact synergistically with steroid receptors. Science 242:1418-1420.
51. Brüggemeier U, Kalff M, Franke S, Scheidereit C, Beato M (1991). Ubiquitous transcription factor OTF-1 mediates induction of the mouse mammary tumour virus promoter through synergistic interaction with hormone receptors. Cell 64:565-572.
52. Rigaud G, Roux J, Pictet R, Grange T (1991). In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67:977-986.
53. Miner JN, Yamamoto KR (1991). Regulatory Crosstalk at Composite Response Elements. Trends Biochem Sci 16:423-426.
54. Mordacq JC, Linzer DIH (1989). Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression. Genes & Develop 3:760-769.
55. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990). Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
56. Miner JN, Yamamoto KR (1992). The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Gene Develop 6:2491-2501.
57. Pearce D, Yamamoto KR (1993). Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165.
58. Vardimon L, Fox LL, Degenstein L, Moscona AA (1988). Cell contacts are required for induction by cortisol of glutamine synthetase gene transcription in the retina. Proc Natl Acad Sci USA 85:5981-5985.
59. Zhang H, Young AP (1991). A single upstream glucocorticoid response element juxtaposed to an AP1/ATF/CRE-like site renders the chicken glutamine synthetase gene hormonally inducible in transfected retina. J Biol Chem 266:24332-24338.
60. Berko-Flint Y, Levkowitz G, Vardimon L (1994). Involvement of c-Jun in the control of glucocorticoid receptor transcriptional activity during development of chicken retinal tissue. EMBO J 13: 646-654.
61. Reisfeld S, Vardimon L (1994). Cell to cell contacts control the transcription activity of the glucocorticoid receptor. Mol Endocrinol 8:1224-1233.
62. Bendror I, Havazelet N, Vardimon L (1993). Developmental control of glucocorticoid receptor transcriptional activity in embryonic retina. Proc Natl Acad Sci USA 90:1117-1121.
63. Benor S, Okret S (1993). Involvement of a C/EBP-like protein in the acquisition of responsiveness to glucocorticoid hormones during chick neural retina development. Mol Cell Biol 13:331-340.
64. Schüle R, Evans RM (1991). Cross-Coupling of Signal Transduction Pathways - Zinc Finger Meets Leucine Zipper. Trends Genet 7:337-381.
65. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990). Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
66. Jonat C, Rahmsdorf H, Park K, Cato A, Gebel S, Ponta H, Herrlich P (1990). Antitumor promotion and antiinflamation: Down-regulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
67. König H, Ponta H, Rahmsdorf HJ, Herrlich P (1992). Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11:2241-2246.
68. Lucibello FC, Slater EP, Joos KU, Beato M, Müller R (1990). Mutual transpression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J 9:2827-2834.
69. Yang-Yen H-F, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J, Karin M (1990). Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
70. Shemshedini L, Knauthe R, Sassone-Corsi P, Pornon A, Grone meyer H (1991). Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J 10:3839-3849.
71. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato ACB (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087-4095.
72. Helmberg A, Auphan N, Gaelics C, Karin M (1995). Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14: 452-460.
73. Liu W, Hillmann AG, Harmon JM (1995). Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors. Mol Cell Biol 15:1005-1013.
74. Webb P, Lopez GN, Uht RM, Kushner PJ (1995). Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456.
75. Gauthier JM, Bourachot B, Doucas V, Yaniv M, Moreau-Gachelin F (1993). Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J 12: 5089-5096.
76. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K (1994). Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kB is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269: 13289-13295.
77. Ray A, Prefontaine KE (1994). Physical association and functional antagonism between the p65 subunit of transcription factor NF-τB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756.
78. Ray A, Siegel MD, Prefontaine KE, Ray P (1995). Anti-inflammation: direct physical association and functional antagonism between transcription factor NF-κB and the glucocorticoid recep-tor. Chest 107:5139.
79. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT (1995). Negative cross-talk between ReIA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412.
80. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS (1995). Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 15:943-953.
81. Scheinman RI, Cosgswell PC, Lofquist AK, Baldwin AS (1995). Role of transcriptional activation of I-kBα in mediation of immu-nosuppression by glucocorticoids. Science 270:283-286.
82. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995). Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
83. Chang TJ, Scher BM, Waxman S, Scher W (1993). Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol Endocrinol 7:528-542.
84. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M (1994). Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367: 476-480.
85. Dedhar S, Rennie PS, Shago M, Hagesteijn CYL, Yang HL, Filmus J, Hawley RG, Bruchovsky N, Cheng H et al. (1994). Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483.
86. Dedhar S ( 1994). Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem Sci 19:269-271.
87. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW (1991). Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254:1636-1639.
88. O'Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, Clark JH (1995). An alternative ligand-independent pathway for activation of steroid receptors. In: CW Bardin (eds), Book. Academic Press Inc, 525 B Street, Suite 1900, San Diego, CA 92101-4495, pp. 333-347.
89. Smith CL, Conneely OM, O'Malley BW (1993). Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90:6120-6124.
90. Aronica SM, Kraus WL, Katzenellenbogen BS (1994). Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521.
91. Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DP (1993). The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA 90:4441-4445.
92. Nordeen SK, Bona BJ, Moyer ML (1993). Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase-A. Mol Endocrinol 7:731-742.
93. Moyer ML, Borror KC, Bona BJ, DeFranco DB, Nordeen SK (1993). Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J Biol Chem 268:22933-22940.
94. Nordeen SK, Moyer ML, Bona BJ (1994). The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology 134:1723-1732.
95. Kato S, Endoh H, Masuhiro Y, Kitamoto Y, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E et al. (1995). Activation of the estrogen receptor by Ras through phosphorylation by mitogen-activated protein kinase. Science (in press).
96. Schmid E, Schmid W, Jantzen M, Mayer D, Jastorff B, Schütz G (1987). Transcription activation of the tyrosine aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes. Eur J Biochem 165:499-506.
97. Ruppert S, Boshart M, Bosch FX, Schmid W, Fournier REK, Schütz G (1990). Two genetically defined trans-acting loci coordinately regulate overlapping sets of liver-specific genes. Cell 61: 895-904.
98. Espinás ML, Roux J, Pictet R, Grange T (1995). Glucocorticoids and protein kinase A coordinately modulate transcription factor recruitment at a glucocorticoid-responsive unit. Mol Cell Biol 15: 5346-5354.
99. Weisz A, Bresciani F (1993). Estrogen regulation of protooncogenes coding for nuclear proteins. Critical Rev Oncogen 4: 361-388.
100. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL (1993). Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13:3577-3587.
101. Sicinski P, Donaher JL, Parker SB, Li TS, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
102. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneeely OM, O'Malley BW (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalites. Genes & Dev 9:2266-2278.
103. Migliaccio A, DiDomenico M, Castoria G, de Falco A, Nola E, Auricchio F (1995). Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J (in press).
104. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS (1992). Coupling of dual signaling pathways. Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662.
105. Matsuda S, Kadowaki Y, Ichino M, Akiyama T, Toyoshima K, Yamamoto T (1993). 17β-estradiol mimics ligand activity of the c-erb B2 protooncogen product. Proc Natl Acad Sci USA 90: 10803-10807.
106. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K et al. (1995). Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes * Dev 9:1608-1621.
107. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162-11166.
108. Nikolov DB, Chen H, Halay ED, Usheva AA, Hisatake K, Lee DK, Roeder RG, Burley SK (1995). Crystal structure of TFIIB-TBP-TATA-element ternary complex. Nature 377:119-128.
109. Lee S, Hahn S (1995). Model for binding of transcription factor TFIIB to the TBP-DNA complex. Nature 376:609-612.
110. Giese K, Cox J, Grosschedl R (1992). The HMG domain of lymphoid enhancer factor-1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185-195.
111. Love JJ, Li XA, Case DA, Giese K, Grosschedl R, Wright PE (1995). Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376:791-795.
112. Oñate SA, Prendergast P, Wagner JP, Nissen M, Reeves R, Pettijohn DE, Edwards DP (1994). The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol 14:3376-3391.
113. Verrier CS, Bailey LR, Yee CJ, Roodi N, Jensen RA, Bustin M, Pari FF (1995). The interaction of the estrogen receptor with its DNA response element is facilitated by the high mobility group protein, HMG-1. Protein Eng 8:78.
114. Thomas GH, Elgin SCR (1988). Protein/DNA architecture of the DNaseI hypersensitive region of the Drosophila hsp26 promoter. EMBO J 7:2191-2201.
115. Schild C, Claret FX, Wahli W, Wolffe AP (1993). A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin-B1 promoter in vitro. EMBO J 12:423-433.
116. Cullen KE, Kladde MP, Seyfred MA (1993). Interaction between transcription regulatory regions of prolactin chromatin. Science 261:203-206.
117. Winston F, Carlson M (1992). Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet 8: 387-391.
118. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR (1992). Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258:1598-1604.
119. Tamkun JW, Deuring R, Scott MP, Kissinger M, Pattatucci AM, Kaufman TC, Kennison JA (1992). brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68:561-572.
120. Muchardt C, Yaniv M (1993). A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila-brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 12:4279-4290.
121. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR (1993). BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366:170-174.
122. Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR (1994). Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature 370:477-481.
123. Côte J, Quinn J, Workmann JL, Peterson CL (1994). Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265:53-59.
124. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP (1994). The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119-130.
125. Singh P, Coe J, Hong WJ (1995). A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374:562-565.
126. Tsukiyama T, Wu C (1995). Purification and properties of an ATP-dependent nucleosome remodelling factor. Cell (in press).
127. Tsukiyama T, Daniel C, Tamkun J, Wu C ( 1995). ISWI, a member of the SWI2/SNF2 ATPase family, encodes the 140 kD subunit of the nucleosome remodelling factor, (in press).
128. Beato M (1991). Transcriptional regulation of mouse mammary tumor virus by steroid hormones. Crit Rev Oncogen 2:195-210.
129. Richard-Foy H, Hager GL (1987). Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J 6:2321-2328.
130. Cordingley MG, Riegel AT, Hager GL (1987). Steorid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell 48:261-270.
131. Perlmann T, Wrange Ö (1988). Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J 7:3073-3079.
132. Piña B, Truss M, Ohlenbusch H, Postma J, Beato M (1990). DNA rotational positioning in a regulatory nucleosome is determined by base sequence. An algorithm to model the preferred superhelix. Nucleic Acids Res 18:6981-6987.
133. Archer TK, Cordingley MG, Wolford RG, Hager GL (1991). Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol 11:688-698.
134. Fragoso G, John S, Roberts MS, Hager GL (1995). Nucleosome positioning on the MMTV LTR results from the frequency-biased occupation of multiple frames. Genes & Dev 9:1933-1947.
135. Roberts MS, Fragoso G, Hager GL (1995). Nucleosomes reconstituted in vitro on Mouse Mammary Tumor Virus B region DNA occupy multiple translational and rotational frames. Biochemistry 34:12470-12480.
136. Truss M, Bartsch J, Schelbert A, Haché RJG, Beato M (1995). Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14:1737-1751.
137. Zaret KS, Yamamoto KR (1984). Reversible and persistent changes in chromatin structure accompanying activation of a glucocorticoid-dependent enhancer element. Cell 38:29-38.
138. Brüggemeier U, Rogge L, Winnacker EL, Beato M (1990). Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J 9:2233-2239.
139. Möws C, Preiss T, Slater EP, Cao X, Verrijzer CP, van der Vliet P, Beato M (1994). Two independent pathways for transcription from the MMTV promoter. J Steroid Biochem Molec Biol 51:21-32.
140. Chávez S, Candau R, Truss M, Beato M (1995). Constitutive repression and nuclear factor I-dependent hormone activation of the Mouse Mammary Tumor Virus promoter in yeast. Mol Cell Biol 15:
141. Candau R, Chávez S, Beato M (1996). The hormone responsive region of Mouse Mammary Tumor Virus positions a nucleosome and precludes access of nuclear factor I to the promoter. J Steroid Biochem Molec Biol
142. Truss M, Candau R, Chávez S, Beato M (1995). Transcriptional control by steroid hormones: the role of chromatin. Ciba Found Symp 191:7-23.
143. Li Q, Wrange O (1995). Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol Cell Biol 15:4375-1384.
144. Li Q, Wrange O (1993). Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. Gene Develop 7:2471-2482.
145. Garlatti M, Daheshia M, Slater E, Bouguet J, Hanoune J, Beato M, Barouki R (1994). A functional glucocorticoid-responsive unit composed of two overlapping inactive receptor-binding sites: Evidence for formation of a receptor tetramer. Mol Cell Biol 14:8007-8017.
146. Burch JBE, H. W (1983). Temporal order of chromatin structural changes associated with activation of the major chicken vitrellogenin gene. Cell 33:65-76.
147. Jost JP, Seldran M, Geiser M (1984). Preferential binding of estrogen-receptor complex to a region containing the estrogen-dependent hypomethylation site preceding the chicken vitellogenin II gene. Proc Natl Acad Sci USA 81:429-433.
148. Wilks AF, Cozens PJ, Mattaj IW, Jost JP (1982). Estrogen induces a demethylation at the 5′ end of the chicken vitellogenin gene. Proc Natl Acad Sci USA 79:4252-4255.
149. Bruhat A, Jost JP (1995). In vivo estradiol-dependent dephosphorylation of the represser MDBP-2-hl correlates with the loss of in vitro preferential binding to methylated DNA. Proc Natl Acad Sci USA 92:3678-3682.
150. Nitsch D, Stewart AF, Boshart M, Mestril R, Weih F, Schütz G (1990). Chromatin structure of the rat tyrosine aminotransferase gene relate to the function of its cis-acting elements. Mol Cell Biol 10:3334-3342.
151. Fritton HP, Sippel AE, Igo-Kemenes T (1983). Nuclease-hypersensitive sites in the chromatin domain of the chicken lysozyme gene. Nucl Acids Res 11:3467-3485.
152. Jantzen C, Fritton HP, Igo-Kemenes T, Espel E, Janich S, Cato ACB, Mugele K, Beato M (1987). Partial overlapping of binding sequences for steroid hormone receptors and DNaseI hypersensitive sites in the rabbit uteroglobin gene region. Nucl Acids Res 15:4535-4552.
153. Elgin SCR (1988). The formation and function of DNaseI hypersensitive sites in the process of gene activation. J Biol Chem 263: 19259-19262.
154. Weih F, Nitsch D, Reik A, Schütz G, Becker PB (1991). Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J 10:2559-2567.
155. Reik A, Schütz G, Stewart AF (1991). Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: induction leads to a reversible disruption of nucleosomes over an enhancer. EMBO J 10:2569-2576.
156. Carr KD, Richard-Foy H (1990). Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat amino transferase promoter in hepatoma cells. Proc Natl Acad Sci USA 87:9300-9304.
157. Hebbes TR, Thorne AW, Crane-Robinson C (1988). A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 7:1395-1402.
158. Vettese-Dadey M, Walter P, Chen H, Juan L-J, Workman JL (1994). Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nulceosomal cores. Mol Cell Biol 14:970-981.
159. Juan L-J, Utley RT, Adams CC, Vettese-Dadley M, Workman JL (1994). Differential repression of transcription factor binding by histone H1 is regulated by the core histone amino termini. EMBO J 13:6031-6040.
160. Lee DY, Hayes JJ, Pruss D, Wolffe AP (1993). A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72:73-84.
161. Bresnick EH, John S, Berard DS, LeFebvre P, Hager GL (1990). Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc Natl Acad Sci USA 87:3977-3981.
162. Yoshida M, Kijima M, Akita M, Beppu T (1990). Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174-17179.
163. Hayes JJ, Wolffe AP (1992). Histones H2A/H2B inhibit the interaction of transcription factor-IIIA with the Xenopus borealis somatic 5S RNA gene in a nucleosome. Proc Natl Acad Sci USA 89:1229-1233.
164. Peterson CL, Herskowitz I (1992). Characterization of the yeast SWI1, SWI2, and SWI2 genes, which encode a global activator of transcription. Cell 68:573-583.
165. Cairns LA, Crotta S, Minuzzo M, Moroni E, Granucci F, Nicolis S, Schiró R, Pozzi L, Giglioni B et al. (1994). Immortalization of multipotent growth-factor dependent hemopoietic progenitors from mice transgenic for GATA-1 driven SV40 tsA58 gene. EMBO J 13:4577-4586.
166. Peterson CL, Dingwall A, Scott MP (1994). Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proc Natl Acad Sci USA 91:2905-2908.
167. Hecht A, Laroche T, Strahl-Bolsinger S, Gasser SM, Grunstein M (1995). Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins: a molecular model for the formation of heterochromatin in yeast. Cell 80:583-592.
168. Van Holde KE (1993). The omnipotent nucleosome. Nature 362: 111-112.
169. Hayes JJ, Wolffe AP (1993). Preferential and asymmetric interaction of linker histones with 5S DNA in the nucleosome. Proc Natl Acad Sci USA 90:6415-6419.
170. Bresnick EH, Bustin M, Marsaud V, Richard-Foy H, Hager GL (1992). The transcriptionally-active MMTV promoter is depleted of histone H1. Nucl Acids Res 20:273-278.
171. Ura K, Hayes JJ, Wolffe AP (1995). A positive role for nucleosome mobility in the transcriptional activity of chromatin templates: restriction by linker histones. EMBO J 14:3752-3765.
172. Catelli MG, Binart N, Jung-Testas I, Renoir JM, Baulieu EE, Feramisco JR, Welch WJ (1985). The common 90 Kd protein component of non-transformed "8S" steroid receptors is a heat-shock protein. EMBO J 4:3131-3135.
173. Smith DF, Toft DO (1993). Minireview - steroid receptors and their associated proteins. Mol Endocrinol 7:4-11.
174. Renoir JM, Radanyi C, Faber LE, Baulieu EE (1990). The non-DNA-binding heterooligomeric form of mammalian steroid hormone receptors contains a hsp90-bound 59-kDa protein. J Biol Chem 265:10740-10745.
175. LaCasse EC, Lochnan HA, Walker P, Lefebvre YA (1993). Identification of binding proteins for nuclear localization signals of the glucocorticoid and thyroid hormone receptors. Endocrinology 132: 1017-1025.
176. Blobel GA, Sieff CA, Orkin SH (1995). Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor. Mol Cell Biol 15:3147-3153.